TREM2, a receptor on the surface of macrophages, could play an important role in atherosclerosis

A publication in Nature Cardiovascular Research from the University Hospital Würzburg (UKW) and the Medical University of Vienna investigates the mechanisms by which the receptor TREM2 affects atherosclerosis and a possible therapeutic approach using an agonistic TREM2 antibody.